Tissue Microarray Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 10.30 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Tissue Microarray Market Analysis
The tissue microarray market is expected to register a CAGR of more than 10.3% during the forecast period.
- The COVID-19 pandemic was an unprecedented health concern and had significantly impacted the tissue microarray market. The pandemic turned a spotlight on the molecular diagnostics industry worldwide, with the rapid development of diagnostics, fast-tracked regulatory clearances, and ramped-up distribution in various regions to help curb the spread of the virus. For instance, as of January 2022, a published article in Karger had reported that tissue microarrays incorporating a total of 879 tissue cores from conjunctival (n = 84), sinonasal (n = 95), and lung (bronchiolar/alveolar; n = 96) specimens were investigated for protein expression by immunohistochemistry. The study confirmed and extended previous findings and contributed to a better understanding of potential SARS-CoV-2 infection sites along the human respiratory tract. Such studies had indicated significant demand for tissue microarray products amid the pandemic. Also, with the introduction of vaccine development and the upliftment of lockdown restrictions, the market was expected to witness positive growth in the coming period.
- The growth of the market can be attributed to factors such as growing research and development in drug discovery, the rising burden of cancer, and increasing demand for accurate diagnostic methods.
- The rising prevalence of cancer is driving the demand for tissue microarray products. For instance, the increasing cancer burden is one of the major factors driving the market. According to the International Agency for Research on Cancer (IARC) 2023, the global incidence of cancer is expected to reach 24.6 million by the year 2030 and 30.2 million by 2040. Furthermore, according to the Cancer Statistics Japan 2023, there were 96,400 prostate cancer cases diagnosed in Japan in 2022, compared to 95,400 in 2021. Thus, the demand for tissue microarrays is increasing in cancer research to analyze the biopsy or tumor samples, thereby anticipated to drive the market growth.
- Additionally, strategic initiatives taken by market players are also propelling the growth of the market. For instance, in March 2021, Oxford BioDynamics Plc and Agilent Technologies signed a supply and resale agreement for the manufacture and sale of the new EpiSwitch Explorer Array Kit. Furthermore, in March 2023, 3DHISTECH, a manufacturer of digital slide scanners, software applications for digital slides, and other products, including tissue microarray machines, and Epredia, a member of the PHC Group (headquartered in Japan) inaugurated a Pathology Innovation Incubator to develop methods and equipment for faster and more precise diagnosis of cancer and tumor lesions. Therefore, the partnership among key players is anticipated to contribute to the market studied due to the increased adoption of microarrays.
- Furthermore, the rising applications of tissue microarray in high throughput screening are anticipated to bolster the market growth. For instance, according to the study published in Scientific Reports in November 2022, tissue microarrays are frequently used for the rapid analysis of large numbers of tissue samples, and the use of tissue microarrays is increasing in spectroscopic analysis, where specific molecular markers are targeted via immunostaining.
- Moreover, with the increase in the spending on research and development, there is increased adoption of tissue microarrays in the testing of drugs and biologics, driving the market growth. For instance, as per the PhRMA in July 2022, during the past 20 years, member companies have spent more than USD 1.1 trillion on the research and development of new medications. Therefore, the rising investments in R&D will lead to increased demand for tissue microarrays in the testing of samples, thereby propelling the market growth.
- However, the availability of alternative technologies and the high cost associated with microarray techniques are the factors hindering market growth.
Tissue Microarray Market Trends
Immunohistochemistry Segment is Expected to Hold a Significant Market Share in the Tissue Microarray Market
- Immunohistochemistry is one of the most common applications of immunostaining. It involves the process of selectively identifying antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.
- The major factors fueling segment growth are the increasing application of immunohistochemistry in tissue diagnostics and the growing research and development. For instance, as per the study published in February 2022 in Scientific Reports, a novel detection technique for activated Rac/Cdc42 in human cancer FFPE tissues was developed by scientists using a developed rapid immunohistochemistry (R-IHC) device. The device helps in carrying out antigen-antibody reactions that can be facilitated up to 1,200-fold by alternating current-based high-speed micro agitation. Such advantages of microarrays in immunohistochemistry research are expected to drive market growth due to increased adoption.
- Additionally, the launch of new products is also propelling the market's growth due to the increased adoption of biotechnological research. For instance, in March 2021, Roche launched the DISCOVERY Green HRP kit. It is the newest addition to the comprehensive collection of modular-based detection kits to identify and profile biomarkers and cell populations in tissue-based research. The DISCOVERY Green HRP (horseradish peroxidase) kit can be used in combination with other detection kits, expanding the multiplexing capability of both immunohistochemistry (IHC) and in situ hybridization (ISH) by providing a distinct color that contrasts with other chromogens.
- Thus, due to the rising initiatives from the key market players and increasing applications of immunohistochemistry, the market is expected to witness significant growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
- In North America, the United States has held a major share of the market. The major factors contributing to the market growth are the presence of many market players engaged in manufacturing and expanding the portfolio of instruments and reagents for molecular diagnostic testing. The region also witnesses the presence of well-established healthcare diagnostic facilities.
- According to the American Cancer Society 2023, 1.9 million new cancer cases are expected to be diagnosed in the United States in 2023. Furthermore, according to the Government of Canada, in June 2022, an estimated 233,900 people in Canada will be diagnosed with cancer 2022. Such a huge incidence of cancers in North America is therefore expected to drive market growth in this region due to the increased adoption of tissue microarray for cancer research in the region.
- Strategic initiatives adopted by the key market players are anticipated to drive market growth. For instance, in January 2022, Histobiolab, a division of Creative Bioarray, reported that it had developed a professional tissue microarray to meet precise research needs. In addition, in July 2021, BioIVT acquired Tissue Solutions Ltd, a provider of high-quality human tissue and other biological materials for use in drug discovery, target identification and validation, assay development and validation, and biomarker and companion diagnostic development. Such launches and partnerships in the region helps in reaching out to a large client base, driving the market growth.
- Thus, the factors such as rising incidence of cancers and initiatives adopted by the key market players are expected to witness significant growth over the forecast period.
Tissue Microarray Industry Overview
The tissue microarray market is moderately competitive, with the presence of several global and international market players. The factors owing to the competition include key players adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some players operating in the market are Novus Biologicals, OriGene Technologies, Inc., ProteoGenex, PREMIER Biosoft, and BioIVT, among others.
Tissue Microarray Market Leaders
-
Novus Biologicals
-
OriGene Technologies, Inc
-
ProteoGenex
-
PREMIER Biosoft
-
BioIVT
*Disclaimer: Major Players sorted in no particular order
Tissue Microarray Market News
- May 2023: PathogenDx planned to launch a microarray-based test for urinary tract infections in late 2023. The new urinary tract infection assay will help in the identification of 26 pathogens and 20 associated antimicrobial resistance genes in one multiplexed test and favor targeted therapies for patients.
- March 2023: TriMetis Life Sciences, a tissue technology company, and ISENET, a leading biomedical instrument design and manufacturing company, entered a new collaboration to offer an automated tissue coring system that will revolutionize genomic profiling services.
Tissue Microarray Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Research and Development in Drug Discovery
- 4.2.2 Rising Burden of Cancer
- 4.2.3 Increasing Demand For Accurate Diagnostic Methods
-
4.3 Market Restraints
- 4.3.1 Availability of Alternative Techniques
- 4.3.2 High Cost Associated With Microarray Techniques
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value- USD million)
-
5.1 By Procedure
- 5.1.1 Immunohistochemistry
- 5.1.2 Fluorescence in situ hybridization (FISH)
- 5.1.3 In Situ Hybridization
- 5.1.4 Other Procedure Types
-
5.2 By Technology
- 5.2.1 Polymerase Chain Reaction (PCR)
- 5.2.2 Next-Generation Sequencing
- 5.2.3 DNA Microarray
- 5.2.4 Other Technology Types
-
5.3 By End-User
- 5.3.1 Pharmaceutical and Biotechnological Companies
- 5.3.2 Research Organizations
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Novus Biologicals
- 6.1.2 ProteoGenex
- 6.1.3 PREMIER Biosoft
- 6.1.4 OriGene
- 6.1.5 Biocompare
- 6.1.6 BioIVT
- 6.1.7 US Biolab
- 6.1.8 Arrayit Corporation
- 6.1.9 Protein Biotechnologies
- 6.1.10 Applied Microarrays
- 6.1.11 BioCat GmbH
- 6.1.12 Bio SB
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityTissue Microarray Industry Segmentation
Tissue microarrays are referred to as paraffin blocks produced by extracting cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a single recipient (microarray) block at defined array coordinates.
The tissue microarray market is segmented by procedure (immunohistochemistry, fluorescence in situ hybridization (FISH), in situ hybridization, and other product types), technology (polymerase chain reaction, next-generation sequencing, DNA microarray, and other technology types), end-user (pharmaceutical and biotechnological companies, and research organizations, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD) for the above segments.
| By Procedure | Immunohistochemistry | |
| Fluorescence in situ hybridization (FISH) | ||
| In Situ Hybridization | ||
| Other Procedure Types | ||
| By Technology | Polymerase Chain Reaction (PCR) | |
| Next-Generation Sequencing | ||
| DNA Microarray | ||
| Other Technology Types | ||
| By End-User | Pharmaceutical and Biotechnological Companies | |
| Research Organizations | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Tissue Microarray Market Research FAQs
What is the current Global Tissue Microarray Market size?
The Global Tissue Microarray Market is projected to register a CAGR of greater than 10.30% during the forecast period (2024-2029)
Who are the key players in Global Tissue Microarray Market?
Novus Biologicals, OriGene Technologies, Inc, ProteoGenex, PREMIER Biosoft and BioIVT are the major companies operating in the Global Tissue Microarray Market.
Which is the fastest growing region in Global Tissue Microarray Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Tissue Microarray Market?
In 2024, the North America accounts for the largest market share in Global Tissue Microarray Market.
What years does this Global Tissue Microarray Market cover?
The report covers the Global Tissue Microarray Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Tissue Microarray Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Tissue Microarray Industry Report
Statistics for the 2023 Tissue Microarray market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Tissue Microarray analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
